Introduction and overview

[1] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J]. NATURE, 1994, 369 (6483) : 756 - 758

[2] EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH-MUSCLE CELL-DNA SYNTHESIS - INHIBITION OF BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506 [J]. TRANSPLANTATION, 1995, 59 (03) : 390 - 395

[3] A PUTATIVE SIROLIMUS (RAPAMYCIN) EFFECTOR PROTEIN [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) : 1 - 7

[4] RAPT1, A MAMMALIAN HOMOLOG OF YEAST TOR, INTERACTS WITH THE FKBP12 RAPAMYCIN COMPLEX [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12574 - 12578

[5] DIASIO RB, 1996, GOODMAN GILMANS PHAR, P1291

[6] Dumont Francis J., 1996, P133

[7] NUCLEAR-ASSOCIATION OF A T-CELL TRANSCRIPTION FACTOR BLOCKED BY FK-506 AND CYCLOSPORINE-A [J]. NATURE, 1991, 352 (6338) : 803 - 807

[8] Pharmacokinetics and metabolism of sirolimus [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (01) : 31 - 35

[9] An immunoassay for the measurement of sirolimus [J]. CLINICAL THERAPEUTICS, 2000, 22 : B49 - B61

[10] Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial [J]. TRANSPLANTATION, 1999, 68 (10) : 1526 - 1532

[1] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J]. NATURE, 1994, 369 (6483) : 756 - 758

[2] EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH-MUSCLE CELL-DNA SYNTHESIS - INHIBITION OF BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506 [J]. TRANSPLANTATION, 1995, 59 (03) : 390 - 395

[3] A PUTATIVE SIROLIMUS (RAPAMYCIN) EFFECTOR PROTEIN [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) : 1 - 7

[4] RAPT1, A MAMMALIAN HOMOLOG OF YEAST TOR, INTERACTS WITH THE FKBP12 RAPAMYCIN COMPLEX [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12574 - 12578

[5] DIASIO RB, 1996, GOODMAN GILMANS PHAR, P1291

[6] Dumont Francis J., 1996, P133

[7] NUCLEAR-ASSOCIATION OF A T-CELL TRANSCRIPTION FACTOR BLOCKED BY FK-506 AND CYCLOSPORINE-A [J]. NATURE, 1991, 352 (6338) : 803 - 807

[8] Pharmacokinetics and metabolism of sirolimus [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (01) : 31 - 35

[9] An immunoassay for the measurement of sirolimus [J]. CLINICAL THERAPEUTICS, 2000, 22 : B49 - B61

[10] Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial [J]. TRANSPLANTATION, 1999, 68 (10) : 1526 - 1532